The incubation with PSMA-positive prostate cancer cell resulted in promoting up to four times more cellular uptake of chimeras than their monovalent A10-3 aptamer-EEF2 shRNA chimera, therefore enhancing RNAi efficacy. This evidence concerns the gene FOLH1 and prostate cancer.